The latest biotech news

News and Trends 19 Jul 2022

CN Bio opens new lab to meet increasing market demand for organ-on-chip research services

New laboratory facilities have been opened today (July 19) at UK organ-on-chip company CN Bio to meet market demand. The Cambridge-based company’s laboratory space has doubled in response to an increasing need for services as the technology gains traction within drug discovery and development programs. Microphysiological systems CN Bio concentrates on designing single and multi-organ […]

July 19, 2022 - 2 minutesmins - By Liza Laws

News and Trends 19 Jul 2022

Spider silk to be produced for Kraig Biocroft Laboratories after agreement signed

Hundreds of kilograms of spider silk will be produced per month after Kraig Biocraft Laboratories joined forces with a contractor. Kraig Labs is a biotechnology company and wants to focus on the development and commercialization of spider silk and expects to achieve its target production levels as early as the first quarter of next year […]

July 19, 2022 - 3 minutesmins - By Liza Laws

News and Trends 19 Jul 2022

SINOVAC starts influenza vaccine trial in Chile

Sinovac Biotech Ltd., a provider of biopharmaceutical products in China, has initiated a phase III clinical trial for SINOVAC’s inactivated quadrivalent influenza vaccine in Chile through a collaboration with the Pontificia Universidad Católica de Chile. SINOVAC said the results aim to provide scientific evidence to support its influenza vaccine immunogenicity and protection capacity. This clinical […]

July 19, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 19 Jul 2022

SK Bioscience signs deal with Novavax to manufacture COVID-19 vaccine

South Korean company SK Bioscience has extended its partnership with Novavax, Inc., a U.S. biotechnology company specializing in next-generation vaccines, for the manufacturing and supply of Novavax COVID-19 vaccine targeting Omicron variants in prefilled syringes. SK Bioscience and Novavax signed an agreement for the technology transfer of Novavax proprietary COVID-19 variant antigen materials and manufacturing […]

July 19, 2022 - 2 minutesmins - By Jim Cornall

Optics11 Life receives €5 million in funding for drug development

News and Trends 18 Jul 2022

FORTY51 Ventures closes $43M biotech fund and announces first investment

FORTY51 Ventures has announced the closing of FORTY51 Ventures I, raising $43 million in its first close. FORTY51’s core strategy focuses on company formation and early-stage investments in biotech with geographic emphasis on Switzerland, France and Germany. FORTY51 Ventures will lead or co-lead early rounds (seed and series A) of its growing portfolio, which will […]

July 18, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 18 Jul 2022

Positive results for drug combination used to treat rare blood cancer

Exploratory analysis of anti-cancer drug, navitoclax, combined with ruxolitinib – a medication for the treatment of intermediate or high-risk myelofibrosis (MF) – has given positive results in a study. The data, announced by US biopharma company, AbbVie, comes from cohort 3 of a phase 2 REFINE study in Janus kinase (JAK) inhibitor naïve patients with […]

July 18, 2022 - 3 minutesmins - By Liza Laws

More News! 18 Jul 2022

Purespring Therapeutics and SwanBio Therapeutics announce agreement for use of FunSel screening platform

A licensing agreement for use of the FunSel screening platform has been announced by Purespring Therapeutics and SwanBio. Under the terms of the agreement, SwanBio will license the FunSel screening platform from Purespring to explore new targets for early-stage pipeline programs. SwanBio will have the option to develop any targets identified and to own and […]

July 18, 2022 - 2 minutesmins - By Liza Laws

News and Trends 18 Jul 2022

Ginkgo Bioworks to collaborate with Sumitomo Chemical on animal-free personal care ingredient

Cell programming company Ginkgo Bioworks has launched a new cell programming project as part of a broader collaboration with Japanese company Sumitomo Chemical Co., Ltd. Through the partnership, Sumitomo Chemical will leverage Ginkgo’s codebase and expertise in organism engineering to produce molecules in a sustainable way for products across a broad range of industries. The […]

July 18, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 18 Jul 2022

Trial for drug targeting cancerous tumors begins in China

A phase 1 trial to investigate a drug for treating people with advanced malignant neoplasms has begun in China. HUTCHMED announced the trial of anti-CD47 monoclonal antibody HMPL-A83 on Friday (July 15). It is the thirteenth innovative oncology drug candidate discovered in-house by HUTCHMED and it is the company’s second large molecule drug candidate to […]

July 18, 2022 - 3 minutesmins - By Liza Laws

News and Trends 18 Jul 2022

Oxford Science Enterprises raises £250M

Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses via its partnership with the University of Oxford, has raised a further £250 million ($300 million) in funding. This brings the total amount raised by OSE to more than £850 million ($1 billion) since inception in 2015. These funds […]

July 18, 2022 - 4 minutesmins - By Jim Cornall

geneuro multiple sclerosis neuron viral dna

News and Trends 18 Jul 2022

First-ever Marketing Authorization Application for biosimilar targeting MS filed

An international biotech, with headquarters in Amsterdam, has announced that the European Medicines Agency (EMA) has accepted the first-ever Marketing Authorization Application (MAA) for its biosimilar product. Polpharma Biologics, which is dedicated to the development of biosimilars, announced on Friday (July 15) that natalizumab, similar to Tysabri, which treats multiple sclerosis, has been accepted as […]

July 18, 2022 - 3 minutesmins - By Liza Laws

News and Trends 18 Jul 2022

Enterome and Nestlé Health Science to work on food allergies and inflammatory bowel disease

Enterome, a clinical stage biopharmaceutical company developing immunomodulatory drugs based on its bacterial Mimicry drug discovery platform, has signed a strategic R&D collaboration and license agreement with Nestlé Health Science targeting food allergies and inflammatory bowel disease (IBD). The collaboration aims to develop and commercialize Enterome’s lead EndoMimics pipeline candidate EB1010. EB1010 is a local […]

July 18, 2022 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

CN Bio opens new lab to meet increasing market demand for organ-on-chip research services

Spider silk to be produced for Kraig Biocroft Laboratories after agreement signed

SINOVAC starts influenza vaccine trial in Chile

SK Bioscience signs deal with Novavax to manufacture COVID-19 vaccine

FORTY51 Ventures closes $43M biotech fund and announces first investment

Positive results for drug combination used to treat rare blood cancer

Purespring Therapeutics and SwanBio Therapeutics announce agreement for use of FunSel screening platform

Ginkgo Bioworks to collaborate with Sumitomo Chemical on animal-free personal care ingredient

Trial for drug targeting cancerous tumors begins in China

Oxford Science Enterprises raises £250M

First-ever Marketing Authorization Application for biosimilar targeting MS filed

Enterome and Nestlé Health Science to work on food allergies and inflammatory bowel disease

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!